• New!
    Placeholder

    GHK-Cu

    Product name: GHK-Cu

    Short name: Copper Peptide Complex

    Concentration: 10mg

    Volume: 3ml vial

    Suggested Diluent: Bacteriostatic water

    Molecular Formula: C14H24N6O4Cu

    Product Summary:

    GHK-Cu, or Glycyl-L-histidyl-L-lysine-Copper, is a naturally occurring copper-binding peptide found in human plasma, saliva, and urine. It is composed of three amino acids attached to a copper ion and is known for its powerful regenerative, anti-inflammatory, and tissue-repairing effects.

    Research has shown that GHK-Cu can stimulate collagen and elastin synthesis, improve skin texture, accelerate wound healing, and support hair follicle function. It also plays a key role in DNA repair, nerve regeneration, and modulating inflammatory responses by influencing gene expression.

    GHK-Cu has been widely studied for its cosmetic and medical potential, including its use in anti-aging skin therapies, treatment of chronic wounds, and as a therapeutic agent for lung and nervous system injuries. It also helps restore a healthy copper balance in the body, further supporting cellular repair mechanisms.

    Key Benefits:

    Skin rejuvenation and anti-aging support
    Collagen and elastin stimulation
    Enhanced wound healing
    Hair regrowth support
    Anti-inflammatory effects
    Tissue and nerve repair properties

    Dosage:

    GHK-Cu is sold in vials containing 10mg of lyophilized powder and should be stored under refrigeration after reconstitution. It is stable for shipping without refrigeration. The powder can be reconstituted using bacteriostatic water.

    For example:

    10mg of powder
    2.5ml of bacteriostatic water
    = 4,000 mcg/ml concentration

    At time of dosing, an insulin syringe is used to draw and inject the desired amount.

    In this example:

    A 100 mcg dose = 0.025 ml or “2.5 IU” on an insulin syringe
    A 200 mcg dose = 0.05 ml or “5 IU” on an insulin syringe
    A 400 mcg dose = 0.1 ml or “10 IU” on an insulin syringe

    Typical dosing protocols in research settings range from 100–400 mcg per day, administered subcutaneously or topically depending on the desired outcome. Common cycles are 4–6 weeks on, followed by 2–4 weeks off.

    Note: All compounds are high quality, and are for research purposes only. No statements made on this site or blog have been evaluated by the FDA or any international equivalent. These products are not intended to treat, cure or prevent any disease or illness. All products are strictly for research purposes only. Please refer to our product use and disclaimer for more information.

    $90.00 Add to cart
  • New!
    Placeholder
  • New!
    Placeholder

    Retatrutide

    Product name: Retatrutide

    Short name: Sustained fat loss


    Concentration: 10mg

    Volume: 3ml vial

    Suggested Diluent: Bacteriostatic water


    Molecular Formula: C223H343F3N46070

    Product Summary:

    Retatrutide is a new entrant into the rapidly-expanding space of anti-obesity peptides. It is known as a GGG tri- agonist. This means that Retatrutide works at all of the incretin receptors including GLP-1 and GIP as well as the glucagon receptor itself. Research indicates that retatrutide may be the most effective weight loss peptide yet developed, with some studies showing a rapid and sustained weight loss response as high as 24% of total body weight. Retatrutide is thought to promote weight loss by increasing energy expenditure as well as decreasing energy consumption. It does the former via action at the glucagon receptor and the latter through both central and peripheral appetite control.

    How Does Retatrutide Work?

    In vivo research, in humans, indicates that retatrutide activates and is a full agonist of all of the incretin receptors including GIPR, GLP-1R, and GCGR. Retatrutide was specifically designed to be highly potent at the GIPR and GLP-1R locations. As a result, retatrutide is one of the most potent incretins available and thus has strong effects on both gastric emptying and the central control of hunger/satiety. Research shows that the bulk of retatrutide’s effects are driven by loss of fat mass that is probably the result of a larger and more prolonged reduction in food intake compared to similar peptides. Decreased food intake, especially as occurs early in the use of the peptide, jump starts fat oxidation. This sets the stage for prolonged weight loss by altering basal metabolism and overcoming the hormonal forces that perpetuate obesity.

    The bulk of retatrutide’s benefit is a result of its ability to decrease energy intake via delayed gastric emptying and increased control of hunger signals in the central nervous system.

    Dosage:
 Retatrutide is sold in vials containing 10MG of lyophilised powder which should be stored under refrigeration. (It is acceptable however for them to be mailed unrefrigerated). The contents can be reconstituted by adding a convenient amount of sterile or bacteriostatic water.

    For example:
    10mg of powder
    2 ml of bacteriostatic water equals 5000 mcg/ml
    At time of dosing, an insulin syringe is used to draw and then inject the desired amount. In the above example a 1000mcg (or 0.1mg) dose would require 0.1mL, or “10 IU” as marked on an insulin syringe.

    Retatrutide is generally administered once weekly, at dosages of 1000mcg per administration, for 12-24 weeks. Dosage can be increased to 2mg after 12 weeks.

     

    Note: All compounds are high quality, and are for research purposes only. No statements made on this site or blog have been evaluated by the FDA or any international equivalent. These products are not intended to treat, cure or prevent any disease or illness. All products are strictly for research purposes only. Please refer to our product use and disclaimer for more information.

    $360.00 Add to cart